VYNE Therapeutics Inc. Common Stock — Institutional Ownership
Which tracked institutions hold YARW, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
9
Funds holding
$105888
Total value held
Buying
3 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Ubs Group Ag | $38147 | 58597 | +58597 | NEW BUY |
| 2 | Blackrock, Inc. | $28895 | 44405 | — | Held |
| 3 | Northern Trust Corp | $28421 | 43677 | +20567 | +89.00% |
| 4 | State Street Corp | $10258 | 15765 | — | Held |
| 5 | Barclays Plc | $92 | 141 | +141 | NEW BUY |
| 6 | Wells Fargo & Company/Mn | $42 | 65 | — | Held |
| 7 | Morgan Stanley | $28 | 43 | — | Held |
| 8 | Jpmorgan Chase & Co | $5 | 8 | -138 | -94.52% |
| 9 | Royal Bank Of Canada | $0 | 15 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.